| β2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer BW Renz, R Takahashi, T Tanaka, M Macchini, Y Hayakawa, Z Dantes, ... Cancer cell 33 (1), 75-90. e7, 2018 | 391 | 2018 |
| Prognosis of untreated hepatocellular carcinoma EG Giannini, F Farinati, F Ciccarese, A Pecorelli, GL Rapaccini, ... Hepatology 61 (1), 184-190, 2014 | 277 | 2014 |
| Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ... Journal of hepatology 62 (3), 617-624, 2015 | 226 | 2015 |
| Neoadjuvant chemoradiotherapy and surgery versus surgery alone in resectable pancreatic cancer: a single-center prospective, randomized, controlled trial which failed to … R Casadei, M Di Marco, C Ricci, D Santini, C Serra, L Calculli, M D’Ambra, ... Journal of Gastrointestinal Surgery 19 (10), 1802-1812, 2015 | 201 | 2015 |
| Hypersensitivity reactions related to oxaliplatin (OHP) G Brandi, MA Pantaleo, C Galli, A Falcone, A Antonuzzo, P Mordenti, ... British journal of cancer 89 (3), 477-481, 2003 | 177 | 2003 |
| Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? M Di Marco, R Di Cicilia, M Macchini, E Nobili, S Vecchiarelli, G Brandi, ... Oncology reports 23 (5), 1183-1192, 2010 | 174 | 2010 |
| Development and validation of a new prognostic system for patients with hepatocellular carcinoma F Farinati, A Vitale, G Spolverato, TM Pawlik, T Huo, YH Lee, AC Frigo, ... PLoS medicine 13 (4), e1002006, 2016 | 137 | 2016 |
| Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma A Cucchetti, F Trevisani, A Pecorelli, V Erroi, F Farinati, F Ciccarese, ... Journal of Hepatology 61 (2), 333-341, 2014 | 135 | 2014 |
| Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis P Del Poggio, S Olmi, F Ciccarese, M Di Marco, GL Rapaccini, ... Clinical gastroenterology and hepatology 12 (11), 1927-1933. e2, 2014 | 132 | 2014 |
| Laparoscopic versus open distal pancreatectomy for ductal adenocarcinoma: a systematic review and meta-analysis C Ricci, R Casadei, G Taffurelli, F Toscano, CA Pacilio, S Bogoni, ... Journal of Gastrointestinal Surgery 19 (4), 770-781, 2015 | 128 | 2015 |
| Patients with advanced hepatocellular carcinoma need a personalized management: a lesson from clinical practice EG Giannini, L Bucci, F Garuti, M Brunacci, B Lenzi, M Valente, E Caturelli, ... Hepatology 67 (5), 1784-1796, 2018 | 114 | 2018 |
| Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma G Cabibbo, S Petta, M Barbara, S Attardo, L Bucci, F Farinati, EG Giannini, ... Journal of hepatology 67 (1), 65-71, 2017 | 101 | 2017 |
| Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon S Petta, G Cabibbo, M Barbara, S Attardo, L Bucci, F Farinati, EG Giannini, ... Alimentary pharmacology & therapeutics 45 (1), 160-168, 2017 | 93 | 2017 |
| The changing scenario of hepatocellular carcinoma in Italy: an update F Garuti, A Neri, F Avanzato, A Gramenzi, D Rampoldi, P Rucci, F Farinati, ... Liver International 41 (3), 585-597, 2021 | 84 | 2021 |
| Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use EG Giannini, G Sammito, F Farinati, F Ciccarese, A Pecorelli, ... Cancer 120 (14), 2150-2157, 2014 | 82 | 2014 |
| The evolutionary scenario of hepatocellular carcinoma in Italy: an update L Bucci, F Garuti, B Lenzi, A Pecorelli, F Farinati, EG Giannini, A Granito, ... Liver International 37 (2), 259-270, 2017 | 79 | 2017 |
| Application of the intermediate-stage subclassification to patients with untreated hepatocellular carcinoma EG Giannini, A Moscatelli, G Pellegatta, A Vitale, F Farinati, F Ciccarese, ... Official journal of the American College of Gastroenterology| ACG 111 (1), 70-77, 2016 | 76 | 2016 |
| Comparison between alcohol‐and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome L Bucci, F Garuti, V Camelli, B Lenzi, F Farinati, EG Giannini, F Ciccarese, ... Alimentary pharmacology & therapeutics 43 (3), 385-399, 2016 | 70 | 2016 |
| Neoadjuvant therapy for resectable pancreatic cancer: a new standard of care. Pooled data from 3 randomized controlled trials DL Birrer, H Golcher, R Casadei, SR Haile, R Fritsch, S Hussung, ... Annals of Surgery 274 (5), 713-720, 2021 | 63 | 2021 |
| The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: a multicenter cohort study A Vitale, F Farinati, TM Pawlik, AC Frigo, EG Giannini, L Napoli, ... Liver International 39 (8), 1478-1489, 2019 | 58 | 2019 |
